STOCK TITAN

[Form 4] Viatris Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Insider grant reported: Viatris Inc. director and officer Andrew Enrietti received a grant of 75,401 restricted stock units (RSUs) on 08/15/2025. Each RSU represents the right to one share of Viatris common stock. The RSUs vest in three annual tranches: 25,134 shares vest on 08/15/2026, 25,133 on 08/15/2027, and 25,134 on 08/15/2028. Following the grant, Enrietti beneficially owns 75,401 shares reported as direct ownership. The Form 4 was signed by power of attorney on 08/19/2025 and lists Enrietti's title as Chief Administrative and Transformation Officer.

Assegnazione a dirigente segnalata: Andrew Enrietti, amministratore e dirigente di Viatris Inc., ha ricevuto il 15/08/2025 una concessione di 75.401 unità di azioni vincolate (RSU). Ogni RSU dà diritto a una azione ordinaria Viatris. Le RSU maturano in tre tranche annuali: 25.134 azioni maturano il 15/08/2026, 25.133 il 15/08/2027 e 25.134 il 15/08/2028. Dopo la concessione, Enrietti detiene beneficiariamente 75.401 azioni come proprietà diretta. Il Modulo 4 è stato firmato per procura il 19/08/2025 e indica il titolo di Enrietti come Chief Administrative and Transformation Officer.

Notificación de concesión a insider: Andrew Enrietti, director y ejecutivo de Viatris Inc., recibió el 15/08/2025 una asignación de 75.401 unidades de acciones restringidas (RSU). Cada RSU otorga el derecho a una acción ordinaria de Viatris. Las RSU se consolidan en tres tramos anuales: 25.134 acciones consolidan el 15/08/2026, 25.133 el 15/08/2027 y 25.134 el 15/08/2028. Tras la concesión, Enrietti posee beneficiariamente 75.401 acciones reportadas como propiedad directa. El Formulario 4 fue firmado por poder el 19/08/2025 y declara su cargo como Chief Administrative and Transformation Officer.

임원 주식 부여 신고: Viatris Inc. 이사 겸 임원인 Andrew Enrietti는 2025-08-1575,401 제한 주식 단위(RSU)를 부여받았습니다. 각 RSU는 Viatris 보통주 1주에 대한 권리를 나타냅니다. RSU는 연차별 세 번의 분할로 권리가 확정됩니다: 25,134주는 2026-08-15에, 25,133주는 2027-08-15에, 25,134주는 2028-08-15에 각각 확정됩니다. 부여 후 Enrietti는 직접 소유로 보고된 75,401주를 실질적으로 보유하고 있습니다. 양식 4는 2025-08-19에 위임장으로 서명되었으며 Enrietti의 직함은 Chief Administrative and Transformation Officer로 기재되어 있습니다.

Attribution insider signalée : Andrew Enrietti, administrateur et cadre de Viatris Inc., a reçu le 15/08/2025 une attribution de 75 401 unités d'actions restreintes (RSU). Chaque RSU donne droit à une action ordinaire Viatris. Les RSU acquièrent en trois tranches annuelles : 25 134 actions le 15/08/2026, 25 133 le 15/08/2027 et 25 134 le 15/08/2028. Après l'attribution, Enrietti détient bénéficiairement 75 401 actions déclarées en propriété directe. Le formulaire 4 a été signé par procuration le 19/08/2025 et indique comme titre de poste Chief Administrative and Transformation Officer.

Meldung über Insider-Zuteilung: Andrew Enrietti, Direktor und leitender Angestellter von Viatris Inc., erhielt am 15.08.2025 eine Zuteilung von 75.401 Restricted Stock Units (RSUs). Jede RSU berechtigt zum Erhalt einer Viatris-Stammaktie. Die RSUs vesten in drei jährlichen Tranchen: 25.134 Aktien vesten am 15.08.2026, 25.133 am 15.08.2027 und 25.134 am 15.08.2028. Nach der Zuteilung besitzt Enrietti wirtschaftlich 75.401 Aktien, gemeldet als Direktbesitz. Das Formular 4 wurde am 19.08.2025 per Vollmacht unterzeichnet und führt Enriettis Titel als Chief Administrative and Transformation Officer auf.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine executive equity grant disclosed, showing standard multi-year vesting and direct beneficial ownership of 75,401 shares.

The Form 4 documents a non-derivative compensation grant of restricted stock units to an officer who is also a director. The disclosure includes exact grant size and a clear vesting schedule across three annual tranches, meeting Section 16 reporting requirements. For compliance reviewers, the filing appropriately reports transaction date, ownership form as direct, and the signer acting by power of attorney. No amendments or additional transactions are reported.

TL;DR: Executive compensation award disclosed with standard staggered vesting; information is complete and straightforward for governance review.

The entry specifies that each RSU converts one-for-one into common stock and gives the exact vesting breakdown: 25,134; 25,133; and 25,134 over the next three anniversaries. The report identifies the reporting person’s role as Chief Administrative and Transformation Officer and indicates direct beneficial ownership post-grant. This provides clear governance transparency on executive equity incentives without extraneous detail.

Assegnazione a dirigente segnalata: Andrew Enrietti, amministratore e dirigente di Viatris Inc., ha ricevuto il 15/08/2025 una concessione di 75.401 unità di azioni vincolate (RSU). Ogni RSU dà diritto a una azione ordinaria Viatris. Le RSU maturano in tre tranche annuali: 25.134 azioni maturano il 15/08/2026, 25.133 il 15/08/2027 e 25.134 il 15/08/2028. Dopo la concessione, Enrietti detiene beneficiariamente 75.401 azioni come proprietà diretta. Il Modulo 4 è stato firmato per procura il 19/08/2025 e indica il titolo di Enrietti come Chief Administrative and Transformation Officer.

Notificación de concesión a insider: Andrew Enrietti, director y ejecutivo de Viatris Inc., recibió el 15/08/2025 una asignación de 75.401 unidades de acciones restringidas (RSU). Cada RSU otorga el derecho a una acción ordinaria de Viatris. Las RSU se consolidan en tres tramos anuales: 25.134 acciones consolidan el 15/08/2026, 25.133 el 15/08/2027 y 25.134 el 15/08/2028. Tras la concesión, Enrietti posee beneficiariamente 75.401 acciones reportadas como propiedad directa. El Formulario 4 fue firmado por poder el 19/08/2025 y declara su cargo como Chief Administrative and Transformation Officer.

임원 주식 부여 신고: Viatris Inc. 이사 겸 임원인 Andrew Enrietti는 2025-08-1575,401 제한 주식 단위(RSU)를 부여받았습니다. 각 RSU는 Viatris 보통주 1주에 대한 권리를 나타냅니다. RSU는 연차별 세 번의 분할로 권리가 확정됩니다: 25,134주는 2026-08-15에, 25,133주는 2027-08-15에, 25,134주는 2028-08-15에 각각 확정됩니다. 부여 후 Enrietti는 직접 소유로 보고된 75,401주를 실질적으로 보유하고 있습니다. 양식 4는 2025-08-19에 위임장으로 서명되었으며 Enrietti의 직함은 Chief Administrative and Transformation Officer로 기재되어 있습니다.

Attribution insider signalée : Andrew Enrietti, administrateur et cadre de Viatris Inc., a reçu le 15/08/2025 une attribution de 75 401 unités d'actions restreintes (RSU). Chaque RSU donne droit à une action ordinaire Viatris. Les RSU acquièrent en trois tranches annuelles : 25 134 actions le 15/08/2026, 25 133 le 15/08/2027 et 25 134 le 15/08/2028. Après l'attribution, Enrietti détient bénéficiairement 75 401 actions déclarées en propriété directe. Le formulaire 4 a été signé par procuration le 19/08/2025 et indique comme titre de poste Chief Administrative and Transformation Officer.

Meldung über Insider-Zuteilung: Andrew Enrietti, Direktor und leitender Angestellter von Viatris Inc., erhielt am 15.08.2025 eine Zuteilung von 75.401 Restricted Stock Units (RSUs). Jede RSU berechtigt zum Erhalt einer Viatris-Stammaktie. Die RSUs vesten in drei jährlichen Tranchen: 25.134 Aktien vesten am 15.08.2026, 25.133 am 15.08.2027 und 25.134 am 15.08.2028. Nach der Zuteilung besitzt Enrietti wirtschaftlich 75.401 Aktien, gemeldet als Direktbesitz. Das Formular 4 wurde am 19.08.2025 per Vollmacht unterzeichnet und führt Enriettis Titel als Chief Administrative and Transformation Officer auf.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Enrietti Andrew

(Last) (First) (Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PA 15317

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0 08/15/2025 A 75,401 (1) (1) Common Stock 75,401 $0 75,401 D
Explanation of Responses:
1. Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. 25,134 of the RSUs granted on August 15, 2025 will vest on August 15, 2026, 25,133 will vest on August 15, 2027, and 25,134 will vest on August 15, 2028.
Remarks:
Chief Administrative and Transformation Officer
/s/ Kevin Macikowski, by power of attorney 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Andrew Enrietti report on the Form 4 for VTRS?

He reported a grant of 75,401 restricted stock units (RSUs) on 08/15/2025, representing one share per RSU, with direct beneficial ownership of 75,401 shares.

When do the RSUs granted to Enrietti vest?

The RSUs vest in three annual tranches: 25,134 on 08/15/2026, 25,133 on 08/15/2027, and 25,134 on 08/15/2028.

What position does the reporting person hold at Viatris (VTRS)?

The Form 4 lists Andrew Enrietti as Chief Administrative and Transformation Officer and indicates he is a director and officer.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by /s/ Kevin Macikowski, by power of attorney on 08/19/2025 confirming the reported transaction dated 08/15/2025.
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

11.81B
1.16B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG